CDX-2 Antibody (Immunohistochemistry)

The CDX-2 Antibody is an essential immunohistochemical marker used for diagnosing
colorectal adenocarcinomas and a broad spectrum of
gastrointestinal neoplasms.
CDX-2 is a nuclear homeobox transcription factor involved in the
differentiation and functional regulation of intestinal epithelial cells, especially during embryologic development.

CDX-2 shows specific expression in
colorectal tumors,
intestinal metaplasia of the stomach,
intestinal-type gastric carcinoma, and certain
ovarian carcinomas.
IHC staining typically reveals brown nuclear staining, enabling accurate identification and differentiation of gastrointestinal-origin tumors from other neoplasms.

🔬 Features and Benefits CDX-2 Antibody

• Highly specific marker for colorectal and gastrointestinal tumors
• Produces distinct brown nuclear staining
• Valuable for detecting intestinal metaplasia and ovarian carcinomas
• Compatible with standard IHC staining protocols
• Excellent stability: 18-month shelf life at 2–8 °C

💡 Diagnostic Applications

• Detection of colorectal adenocarcinoma and intestinal-type gastric cancer
• Identification of intestinal metaplasia in gastric biopsies
• Differentiation of gastrointestinal tumors from ovarian carcinomas
• Useful in tumors of unknown origin to determine intestinal differentiation

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the
exclusive representative of Talent Biomedical in Iran, supplies high-quality
immunohistochemistry antibodies, including CDX-2.
The company is dedicated to
scientific precision, diagnostic reliability, and international quality standards, supporting pathology laboratories and molecular diagnostic centers throughout Iran.

“Download Brochure”